VIENNA—Estrogen receptor negative breast cancer might be prevented by strategies under investigation including HER2-targeting, vaccination and treatment with metformin or retinoids. Powel Brown MD, Chairman of the Department of Clinical Cancer Prevention at the University of Texas MD Anderson Cancer Center in Houston, summarized the evidence for Oncology Times reporter Sarah.
You may also like...
Prostate Genomics—Which Patients Will Die? 20 Apr, 2017 Endocrine Therapy in Premenopausal Breast Cancer: Most Effective Not Always Best 24 Mar, 2015 Two-step immunotherapy brings promise in advanced ovarian cancer 8 Apr, 2013 Which patients for bisphosphonate control of breast cancer metastasis? 29 Mar, 2013
- Previous story Preventing ER-Positive Breast Cancer—Latest from IBIS 1, 2 and 3
- Next story Genetic Tests for Breast Cancer Late Recurrence Risk—Not Yet Ready for Prime Time
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014